Through thought-provoking keynote presentations, ISG Insight sessions, dynamic panels and interactive roundtable discussions, we will dive into the questions that that matter the most for healthcare provider attendees:

• We rushed to implement virtual care services when the pandemic broke out.
  Will the systems we set up be able to withstand the high volumes of virtual visits on a permanent basis?
  If not, how do we implement more stable solutions without interrupting our current care models?
• We understand the benefits of digital transformation and the impact it can have on delivering value-based care, but not everyone is open to change which is hindering adoption.
  What strategies can we put in place as an organization to enable a digital-first culture that will benefit patients, medical professionals, and stakeholders?
• User adoption is proving to be one of our biggest challenges.
  How to we encourage uptick?
• It’s clear that digital solutions are here to stay and we’re ready to adopt.
  How do we ensure that the technology we select complies with HIPPA or other government regulations on data privacy and security?  
• Interoperability is big on our radar - we want real-time data exchange. We’re currently sitting on a stockpile of disparate data and bad data.
  What factors do we need to consider when selecting the right platforms for interconnected data channels?
  What milestones do we need to consider in our interoperability framework?
• What are the opportunities to revolutionize care?

Through thought-provoking keynote presentations, ISG Insight sessions, dynamic panels and interactive roundtable discussions, we will dive into the questions that that matter the most for healthcare provider attendees:

• What challenges have arisen in the pharma space, and how can you overcome these in order to advance post-pandemic?
• What implications do these challenges have on existing patient/consumer groups? 
• How are patient and consumer expectations shifting and what are pharma companies doing to address these evolving expectations? 
• What are pharma companies doing to reinvent their relevance with healthcare providers? 
• How is intelligent automation being used to move towards decentralized trials?
• Hear how a global, values-based, R&D-driven biopharmaceutical company developed a strategy to be consolidated, harmonized, IT infrastructure that benefited both core technology and user experience.